Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation

被引:59
作者
Abdelaziz, Ahmed A. [1 ]
Elbanna, Tarek E. [1 ]
Sonbol, Fatma I. [1 ]
Gamaleldin, Noha M. [1 ]
El Maghraby, Gamal M. [1 ]
机构
[1] Tanta Univ, Coll Pharm, Dept Pharmaceut Technol, Tanta, Egypt
关键词
bacterial biofilm; norfloxacin; Pseudomonas aeruginosa; regrowth assay; surfactant vesicles; PSEUDOMONAS-AERUGINOSA BIOFILM; DRUG-DELIVERY SYSTEMS; ANTIMICROBIAL ACTIVITY; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; CATIONIC LIPOSOMES; SKIN DELIVERY; GENTAMICIN; ENCAPSULATION; EFFLUX;
D O I
10.1517/17425247.2014.942639
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The aim was to optimize norfloxacin niosomes for enhanced antibacterial activity and reduced bacterial resistance. Methods: Pseudomonas aeruginosa, a biofilm forming bacterium, was used as the test organism. Different norfloxacin niosomes were evaluated in vitro and in vivo, respectively, for antibacterial activity compared with aqueous drug solution. The influence of norfloxacin niosomes on biofilm formation was investigated. The interaction of niosomes with bacterial cells was also monitored using the scanning electron microscopy (SEM). Results: The efficacy of niosomes depended on their composition. Standard niosomes of Span 60 and cholesterol were similar to drug solution. Incorporation of Tween 80, oleic acid (OA), OA/propylene glycol or lecithin produced fluid niosomes which reduced the MIC and inhibited biofilm formation compared with drug solution. Incorporation of a positively charged agent into fluid niosomes enhanced the antibacterial activity and reduced biofilm formation significantly. SEM showed evidence of vesicle adsorption to the bacteria with possible adhesion or fusion with the cell membrane. The in vivo skin model confirmed the in vitro results with optimum niosomes being more efficient than drug solution. Conclusion: Niosomes are promising for enhanced antibacterial activity and reduced resistance to antibiotics. The later can be achieved by inhibition of biofilm formation.
引用
收藏
页码:163 / 180
页数:18
相关论文
共 77 条
  • [1] VALIDATED MICROBIOLOGICAL AND HPLC METHODS FOR THE DETERMINATION OF MOXIFLOXACIN IN PHARMACEUTICAL PREPARATIONS AND HUMAN PLASMA
    Abdelaziz, Ahmed A.
    Elbanna, Tarek E.
    Gamaleldeen, Noha M.
    [J]. BRAZILIAN JOURNAL OF MICROBIOLOGY, 2012, 43 (04) : 1291 - 1301
  • [2] Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
    Abdelbary, Ghada
    El-gendy, Nashwa
    [J]. AAPS PHARMSCITECH, 2008, 9 (03) : 740 - 747
  • [3] Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis
    Alam, Maroof
    Zubair, Swaleha
    Farazuddin, Mohammad
    Ahmad, Ejaj
    Khan, Arbab
    Zia, Qamar
    Malik, Abida
    Mohammad, Owais
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (02) : 247 - 256
  • [4] Liposomes for Enhanced Cytotoxic Activity of Bleomycin
    Alomrani, Abdullah H.
    El Maghraby, Gamal M.
    Alanazi, Fars K.
    Al-Mohanna, Mai A.
    Alaiya, Ayodele A.
    Alsarra, Ibrahim A.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (03) : 265 - 273
  • [5] BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
  • [6] Microscopy imaging of liposomes: From coverslips to environmental SEM
    Bibi, Sagida
    Kaur, Randip
    Henriksen-Lacey, Malou
    McNeil, Sarah E.
    Wilkhu, Jitinder
    Lattmann, Eric
    Christensen, Dennis
    Mohammed, Afzal R.
    Perrie, Yvonne
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 417 (1-2) : 138 - 150
  • [7] Bini K., 2012, International Journal of Drug Development and Research, V4, P147
  • [8] Bozzola J.J, 1999, ELECT MICROSCOPY PRI, V2nd ed.
  • [9] Clinical Institute LS, 2006, M7A7 CLIN I LS
  • [10] Multidrug efflux pumps:: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms
    De Kievit, TR
    Parkins, MD
    Gillis, RJ
    Srikumar, R
    Ceri, H
    Poole, K
    Iglewski, BH
    Storey, DG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1761 - 1770